Keryx Biopharmaceuticals, Inc. Debt to Equity Ratio 2010-2018 | KERX
Current and historical debt to equity ratio values for Keryx Biopharmaceuticals, Inc. (KERX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Keryx Biopharmaceuticals, Inc. debt/equity for the three months ending September 30, 2018 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2018-09-30 | $0.21B | $-0.05B | -3.80 |
| 2018-06-30 | $0.19B | $-0.04B | -4.54 |
| 2018-03-31 | $0.17B | $-0.03B | -5.43 |
| 2017-12-31 | $0.17B | $-0.01B | -12.27 |
| 2017-09-30 | $0.17B | $0.01B | 18.40 |
| 2017-06-30 | $0.16B | $0.03B | 6.18 |
| 2017-03-31 | $0.15B | $-0.02B | -6.67 |
| 2016-12-31 | $0.15B | $-0.01B | -18.05 |
| 2016-09-30 | $0.15B | $0.02B | 6.67 |
| 2016-06-30 | $0.15B | $0.06B | 2.54 |
| 2016-03-31 | $0.18B | $0.05B | 3.65 |
| 2015-12-31 | $0.17B | $0.09B | 1.98 |
| 2015-09-30 | $0.03B | $0.12B | 0.28 |
| 2015-06-30 | $0.03B | $0.15B | 0.20 |
| 2015-03-31 | $0.04B | $0.17B | 0.22 |
| 2014-12-31 | $0.03B | $0.07B | 0.41 |
| 2014-09-30 | $0.03B | $0.10B | 0.29 |
| 2014-06-30 | $0.02B | $0.12B | 0.15 |
| 2014-03-31 | $0.02B | $0.14B | 0.11 |
| 2013-12-31 | $0.02B | $0.05B | 0.34 |
| 2013-09-30 | $0.02B | $0.06B | 0.28 |
| 2013-06-30 | $0.01B | $0.07B | 0.16 |
| 2013-03-31 | $0.01B | $0.08B | 0.10 |
| 2012-12-31 | $0.01B | $0.01B | 0.77 |
| 2012-09-30 | $0.01B | $0.02B | 0.46 |
| 2012-06-30 | $0.01B | $0.02B | 0.43 |
| 2012-03-31 | $0.01B | $0.02B | 0.55 |
| 2011-12-31 | $0.01B | $0.03B | 0.40 |
| 2011-09-30 | $0.01B | $0.04B | 0.32 |
| 2011-06-30 | $0.01B | $0.05B | 0.20 |
| 2011-03-31 | $0.01B | $0.02B | 0.53 |
| 2010-12-31 | $0.01B | $0.02B | 0.38 |
| 2010-09-30 | $0.01B | $0.03B | 0.38 |
| 2010-06-30 | $0.01B | $0.03B | 0.33 |
| 2010-03-31 | $0.01B | $0.03B | 0.29 |
| 2009-12-31 | $0.01B | $0.03B | 0.27 |
| 2009-09-30 | $0.01B | $0.04B | 0.30 |
| 2009-06-30 | $0.01B | $0.02B | 0.61 |
| 2009-03-31 | $0.03B | $0.00B | -57.63 |
